GSTP1 and type 2 diabetes mellitus: This highlights that oxidative stress is a potential covariate in predicting patient response to antidiabetic treatment, and GSTP1 genotyping can be relevant for better identification of T2D patients who are likely to need specific pharmacological strategies focusing not only on lowering glucose [29], but also on oxidative stress.